Granules India Limited has reported its financial results for the quarter and year ended March 31, 2026. The company achieved a consolidated annual profit of ₹5,950.21 million on total revenue of ₹53,859.71 million. In addition to these results, the Board of Directors has recommended a final dividend of ₹1.75 per equity share, representing 175% of the face value, and has scheduled the company’s 35th Annual General Meeting for August 6, 2026.
Consolidated Financial Performance
Granules India Limited showed significant growth for the financial year ending March 31, 2026. The company recorded a total annual consolidated revenue of ₹53,859.71 million, up from ₹44,945.27 million in the previous year. Profit for the full year reached ₹5,950.21 million, compared to ₹5,015.16 million in the prior fiscal year, reflecting sustained operational progress.
Dividend and Shareholder Meetings
The Board of Directors has recommended a final dividend of ₹1.75 per share for the financial year 2025-26, based on a face value of ₹1.00. This dividend payout represents 175% of the company’s paid-up equity share capital. Shareholders are advised that the record date for this payment has been set for July 30, 2026. Furthermore, the company has scheduled its 35th Annual General Meeting to be held on Thursday, August 6, 2026.
Strategic Acquisitions and Developments
Throughout the fiscal year, Granules India has focused on strategic expansion. Key developments include the acquisition of Senn Chemicals AG, which became a wholly-owned step-down subsidiary on April 10, 2025. Additionally, the company acquired a 100% equity stake in Granules Pharmaceuticals GmbH (formerly Optus 1039 GmbH) in Germany on November 20, 2025, and incorporated Granules Pharmaceuticals Canada, Inc. in November 2025 to bolster its global reach.
Operational Updates
Regarding its facilities, the company addressed a USFDA warning letter received in February 2025 for its Gagillapur site. In response, the company voluntarily paused operations in September 2024 to implement comprehensive remedial measures, involving independent consultants to upgrade procedures and safety standards, aimed at ensuring long-term operational excellence and compliance.
Source: BSE
